IMMUNOCOMPROMISED
Clinical trials for IMMUNOCOMPROMISED explained in plain language.
Never miss a new study
Get alerted when new IMMUNOCOMPROMISED trials appear
Sign up with your email to follow new studies for IMMUNOCOMPROMISED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Grown donor cells take on dangerous virus in vulnerable patients
Disease control Recruiting nowThis early-stage trial is for people with weakened immune systems who have an adenovirus infection. Researchers are testing a treatment made from donor immune cells grown in a lab to see if it is safe and can help fight the virus. The study involves 16 participants and focuses on…
Matched conditions: IMMUNOCOMPROMISED
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 20:34 UTC
-
New hope for immunocompromised patients with severe parainfluenza
Disease control Recruiting nowThis study tests an experimental drug called DAS181 in people with weakened immune systems who have a serious lung infection caused by parainfluenza virus. The goal is to see if the drug helps them breathe without extra oxygen and reduces the risk of death. About 274 participants…
Matched conditions: IMMUNOCOMPROMISED
Phase: PHASE3 • Sponsor: Ansun Biopharma, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC